126 related articles for article (PubMed ID: 6402571)
1. Relative distribution of diphosphonate between bone and soft tissue at 4 and 24 hours: concise communication.
Smith ML; Martin W; Fogelman I; Bessent RG
J Nucl Med; 1983 Mar; 24(3):208-11. PubMed ID: 6402571
[TBL] [Abstract][Full Text] [Related]
2. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
4. The effect of DMSO treatment on the performance of [99mTc]HEDP.
Bugaj JE; Esser PD; Tofe AJ; Borgia AT; Fawwaz RA
Int J Nucl Med Biol; 1984; 11(2):109-11. PubMed ID: 6434460
[TBL] [Abstract][Full Text] [Related]
5. Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males.
Molloi S; Mazess R; Bendsen H; Wilson M
Calcif Tissue Int; 1989 May; 44(5):322-9. PubMed ID: 2496903
[TBL] [Abstract][Full Text] [Related]
6. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
7. Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
Brenner W; Kampen WU; Brümmer C; von Forstner C; Zuhayra M; Czech N; Muhle C; Henze E
J Nucl Med; 2003 Feb; 44(2):247-51. PubMed ID: 12571217
[TBL] [Abstract][Full Text] [Related]
8. Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera.
Martin W; Fogelman I; Bessent RG
J Nucl Med; 1981 Jun; 22(6):542-5. PubMed ID: 6785399
[TBL] [Abstract][Full Text] [Related]
9. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
[TBL] [Abstract][Full Text] [Related]
10. Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.
Smith ML; Fogelman I; Ralston S; Boyce BF; Boyle IT
Metab Bone Dis Relat Res; 1984; 5(4):167-70. PubMed ID: 6429474
[TBL] [Abstract][Full Text] [Related]
11. Diphosphonates in the evaluation of metabolic bone disease.
Fogelman I; Smith ML
Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
[TBL] [Abstract][Full Text] [Related]
12. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
Fogelman I; Bessent RG; Turner JG; Citrin DL; Boyle IT; Greig WR
J Nucl Med; 1978 Mar; 19(3):270-5. PubMed ID: 564941
[TBL] [Abstract][Full Text] [Related]
13. Measurements of the distribution of technetium-99m sulfur colloid and technetium-99m HEDP in normal humans.
Grossman LW; Sodd VJ; Nishiyama H; Feller PA; Hoops RG
Med Phys; 1983; 10(1):79-82. PubMed ID: 6405144
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
[TBL] [Abstract][Full Text] [Related]
15. A comparison of bone imaging with Tc-99m DPD and Tc-99m MDP: concise communication.
Buell U; Kleinhans E; Zorn-Bopp E; Reuschel W; Muenzing W; Moser EA; Seiderer M
J Nucl Med; 1982 Mar; 23(3):214-7. PubMed ID: 6460854
[TBL] [Abstract][Full Text] [Related]
16. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
Blake GM; Moore AE; Fogelman I
Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
[TBL] [Abstract][Full Text] [Related]
17. A clinical comparison of Tc-99m HEDP and Tc-99m MDP in the detection of bone metastases: concise communication.
Fogelman I; Citrin DL; McKillop JH; Turner JG; Bessent RG; Greig WR
J Nucl Med; 1979 Feb; 20(2):98-101. PubMed ID: 430202
[TBL] [Abstract][Full Text] [Related]
18. A radiopharmaceutical and clinical comparison of 99mTc-Sn-hydroxymethylene diphosphonate with 99mTc-Sn-hydroxyethylidene diphosphonate.
Silberstein EB
Radiology; 1980 Sep; 136(3):747-51. PubMed ID: 6773104
[TBL] [Abstract][Full Text] [Related]
19. In vivo distributions of some component fractions of Tc(NaBH4)-HEDP mixtures separated by anion exchange high performance liquid chromatography.
Pinkerton TC; Ferguson DL; Deutsch E; Heineman WR; Libson K
Int J Appl Radiat Isot; 1982 Oct; 33(10):907-15. PubMed ID: 6818160
[TBL] [Abstract][Full Text] [Related]
20. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion.
Deutsch E; Libson K; Becker CB; Francis MD; Tofe AJ; Ferguson DL; McCreary LD
J Nucl Med; 1980 Sep; 21(9):859-66. PubMed ID: 6774066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
